Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "transADVANcis Marketing Research Consultoria" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about transADVANcis Marketing Research Consultoria for you to read. Along with our medical data and news we also list transADVANcis Marketing Research Consultoria Clinical Trials, which are updated daily. BioPortfolio also has a large database of transADVANcis Marketing Research Consultoria Companies for you to search.
Amarin raises sales guidance for heart drug Vascepa, hires more sales reps for larger marketing push. https://buff.ly/2J5RihG
After a 3 1/2 year legal battle, secret records about Purdue Pharma’s marketing of its potent opioid painkiller OxyContin will finally be made public. https://buff.ly/2zmh0Zr
The company planted the seeds of a public health crisis by marketing to millennials, who had low smoking rates, and it ignored evidence that teenagers were using its products.
An announcement was made by Astellas Pharma and partner Pfizer that its supplemental marketing application for Xtandi, or enz -More-
WATERTOWN, Mass., Nov. 25, 2019 (GLOBE NEWSWIRE) Read more...
Stanford University is addressing a pressing and fascinating question: What happens to society when everyone starts living to 100?
Original-Research: Paion AG - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Paion AG Unternehmen: Paion AG ISIN: DE000A0B65S3 Anlass der Studie: Update ...
Original-Research: Valneva SA - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Valneva SA Unternehmen: Valneva SA ISIN: FR0004056851 Anlass der Studie: H...
Clinical Research News Contributed Commentary | Though academic medical centers (AMCs) may differ widely, they generally share the same tripartite mission: research, medical education, and patient care. Yet, increasingly, complex clinical research systems and processes present common challenges to all of these prestigious institutions, regardless of their differences, that can weigh heavily on res...
The article in BPS Research Digest, a blog that summarizes the latest research on the brain and behavior, is a follow-up to one published last year on the 10 psychological findings that reveal the worst of human nature.
Indegene’s surveys in 2016 and 2019 show a spike in digital spend
HAIFA, Israel, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a platform of novel biological products, today announced results from a market access comprehensive research study conducted by Marwood Group, a healthcare advisory firm, for the critical limb
The agency wants data from six e-cigarette makers, including Juul.
PerkinElmer has obtained marketing authorization from the FDA for its GSP Neonatal Creatine Kinase-MM kit for newborn screeni -More-
Chris Ross explores the ability of creative communications to change minds and habits
This Viewpoint discusses methodological challenges to conducting reliable dietary research relative to processes and standards in place for drug discovery and development, and proposes modifications to the conduct of dietary research to improve its transparency, quality, and reliability.
As the commercialisation arm of Cancer Research UK, Cancer Research Technology (CRT) bridges the gap between academia and industry. Keith Blundy, CEO of CRT, gives his unique perspective on recent developments in immuno-oncology and talks about the most promising areas for early-stage discovery.
UK Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and Opportunities [Published by Venture Planning Group VPG] Prices from US
This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the UK molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.The report explores future marketing and technological trends in UK; provides ...
US Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and Opportunities [Published by Venture Planning Group VPG] Prices from US
This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the US molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.The report explores future marketing and technological trends in US; provides ...
In recent weeks, the firearms controversy has again lit up the media in the United States, with clarification that anyone engaged in the business of selling firearms must get a license and conduct background checks. But, argues Fred Rivara from the Seattle Children’s Research Institute and Harborview Injury Prevention and Research Center, we may...
(UK Research and Innovation) People were less likely to catch either influenza or a common cold-causing rhinovirus if they were already infected with the other virus, a new study by scientists from the Medical Research Council-University of Glasgow Centre for Virus Research has found.
Overuse of antibiotics in healthcare contributes to the development of antibiotic-resistant bacteria, resulting in 2 million infections and 100,000 deaths in the US each year, but research is lacking to inform antibiotic stewardship programs aimed at reining in unnecessary use of these powerful drugs, according to new research.
Edison Investment Research - Pharmaceuticals & healthcare - Acacia Pharma: Following guidance from the US FDA, Acacia Pharma has now outlined the regulatory pathway for its lead asset, BARHEMSYS, and plans to resubmit the new drug application (NDA) in Q319. This could enable a launch in H120 if approved by the FDA. Ongoing deficiencies with Acacia’s chosen contract manufacturing organisation...
Philanthropy and partnerships We know that the global appetite for philanthropic giving is growing. But for someone thinking about giving a gift to charity, there are often a lot of questions. With the help of some of
Research England has announced it will change the weighting of its funding calculations to put mental health research on a par with research into physical health.1The body previously calculated...